Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up

被引:99
作者
Ito, M [1 ]
Tanaka, S
Takata, S
Oka, S
Imagawa, S
Ueda, H
Egi, Y
Kitadai, Y
Yasui, W
Yoshihara, M
Haruma, K
Chayama, K
机构
[1] Hiroshima Univ, Dept Med & Mol Sci, Hiroshima 7348551, Japan
[2] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan
[3] Hiroshima Univ, Dept Mol Pathol, Hiroshima 7348551, Japan
[4] Hiroshima Univ, Hlth Serv Ctr, Hiroshima 7348551, Japan
[5] Kawasaki Med Sch, Dept Internal Med, Gastroenterol Unit, Kurashiki, Okayama, Japan
关键词
D O I
10.1111/j.1365-2036.2005.02360.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: It is controversial as to whether the development of gastric cancer is influenced by Helicobacter pylori eradication. If eradication itself influences the tumour morphology, this may affect the tumour discovery rate. Aim: To investigate the morphological changes in the gastric neoplasm after H. pylori eradication. Methods: We studied 37 patients with eradication therapy. After a 1-month follow-up, endoscopic re-evaluation was performed and the appearance was compared with first image. All lesions were resected endoscopically, and were subjected to histological assessment and to immunohistochemistry. Serum gastrin levels were determined before and after eradication. Results: Twenty-nine of 37 patients underwent successful eradication. The appearance of 11 lesions (33% of 33 lesions) became indistinct after successful eradication. All lesions were of the superficial-elevated type and the height of the lesions decreased. We detected normal columnar epithelium over the neoplasm in eight of the lesions. Higher expression of single-stranded deoxyribonucleic acid in the deep area was characteristic in tumours with an indistinct appearance. These changes did not correlate with the serum gastrin levels. Conclusions: The morphology of the gastric neoplasm change after eradication in the short-term. This may contribute to the decreased tumour discovery rate.
引用
收藏
页码:559 / 566
页数:8
相关论文
共 26 条
[1]
Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells [J].
Asahi, M ;
Azuma, T ;
Ito, S ;
Ito, Y ;
Suto, H ;
Nagai, Y ;
Tsubokawa, M ;
Tohyama, Y ;
Maeda, S ;
Omata, M ;
Suzuki, T ;
Sasakawa, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (04) :593-602
[2]
CORREA P, 1995, AM J SURG PATHOL, V19, pS37
[3]
Eguchi H, 2003, CANCER RES, V63, P4739
[4]
Frankfurt OS, 1996, ANTICANCER RES, V16, P1979
[5]
Haruma K, 1999, ALIMENT PHARM THERAP, V13, P155
[6]
GASTRIC-ACID SECRETION, SERUM PEPSINOGEN-I, AND SERUM GASTRIN IN JAPANESE WITH GASTRIC HYPERPLASTIC POLYPS OR POLYPOID-TYPE EARLY GASTRIC-CARCINOMA [J].
HARUMA, K ;
YOSHIHARA, M ;
SUMII, K ;
TARI, A ;
WATANABE, C ;
KODOI, A ;
KAJIYAMA, G .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1993, 28 (07) :633-637
[7]
Helicobacter pylori infection is a major risk factor for gastric carcinoma in young patients [J].
Haruma, K ;
Komoto, K ;
Kamada, T ;
Ito, M ;
Kitadai, Y ;
Yoshihara, M ;
Sumii, K ;
Kajiyama, G .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2000, 35 (03) :255-259
[8]
SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein [J].
Higashi, H ;
Tsutsumi, R ;
Muto, S ;
Sugiyama, T ;
Azuma, T ;
Asaka, M ;
Hatakeyama, M .
SCIENCE, 2002, 295 (5555) :683-686
[9]
Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia:: a 5-year prospective study of patients with atrophic gastritis [J].
Ito, M ;
Haruma, K ;
Kamada, T ;
Mihara, M ;
Kim, S ;
Kitadai, Y ;
Sumii, M ;
Tanaka, S ;
Yoshihara, M ;
Chayama, K .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (08) :1449-1456
[10]
Kawaguchi H, 1996, AM J GASTROENTEROL, V91, P959